Andrew’s Blog

Meat and the Environment Posted on December 15, 2015, 0 Comments

Original Source found here:

Not eating red meat won’t save the planet

Asa Wahlquist
Published: December 14, 2015 - 9:00PM

Comment: The future of protein is not meat
It sounds so easy: stop eating red meat to lower greenhouse gas emissions. But nature is far more complicated than that.

There are three critical questions you need to ask before cutting beef and lamb out of your diet for environmental reasons: what will happen to the grasslands that cattle and sheep graze; how will alternate protein be produced; and what will the greenhouse consequences of that production be?

About 60 per cent of the world's agricultural land is grasslands, land that is too poor and too dry to be cropped. In Australia, about 70 per cent of the country is grassland. The only way food can be produced from grasslands is by grazing ruminants. Mammals cannot digest grass, but ruminants have special stomachs filled with grass-digesting bacteria. The problem is those bacteria produce methane, which the ruminant burps out.

Methane is a potent greenhouse gas with a rating 25 times that of carbon dioxide over 100 years, although it has a lifetime of 9 to 12 years in the atmosphere.

The experience worldwide is that if cattle are removed from grasslands, the original ruminants re-establish themselves, or ferals invade.

In Australia the main ferals are goats, as well as camels in drier regions. Contrary to popular belief, kangaroos do produce methane, although the actual quantities, and their alternate pathways for digesting cellulose from grass, are the subject of ongoing research. Even termites produce methane: they are responsible for about three per cent of Australia's greenhouse gas emissions.

What if everyone did go vegetarian and the grasslands were not grazed at all? In Australia, they would most likely burn. Bushfire accounts for about 3 per cent of Australia's net greenhouse gas emissions.

The argument overseas focuses largely on the huge quantities of grain, that could otherwise be consumed by humans, that are fed to livestock. This is a practice that is indefensible on environmental grounds. In Australia, most cattle and all sheep are grassfed. Dairy cattle are usually given supplementary feed, which is mostly forage or hay with some grain.

If you decide not to eat meat, where are you going to get your protein, and what are the greenhouse gas consequences? Soy beans, chickpeas, lentils - all the high-protein legumes - are crops that are grown on cleared land, land that is ploughed, fertilised, planted, irrigated and harvested by greenhouse-gas producing machines.

Australia is at its limit of land that can be cleared for cropping, and is in the process of reducing irrigation in its food bowl, the Murray-Darling basin. And talking of irrigation, under Australian conditions soybeans need almost as much water as cotton. Australia produces roughly 15 per cent of the soybeans that it consumes, although much of that is used in stock feed.

Pigs and chickens are monogastric and as a result produce a small fraction, per kilo, of the methane produced by ruminants. Unlike cattle they cannot live on grass. In traditional farm situations they were fed on crop residues and waste, but now significant quantities of grains are grown to feed them.

Meat protein substitutes, ranging from tofu to synthetic meat, are all highly processed and that means more greenhouse gas production.

Estimating methane production is a tricky business. There are a number of figures for the percentage of greenhouse gas emissions agriculture is responsible for, and they are getting better. On Monday, the CSIRO announced methane emissions from Australian cattle were actually 24 per cent lower than previously thought.

Critics of meat consumption like to compare ruminant-produced methane with transport emissions. But fossil fuels are releasing carbon that was sequestered hundreds of millions of years ago that will never be replaced. The methane burped by a cow comes from carbon sequestered in the grass during the last growing season. If that grass keeps growing, or produces seedlings, carbon will be sequestered again next season.

There is no comparison: burning fossil fuels is a one-way street. The methane produced by ruminants is a natural part of an ancient life cycle.

Asa Wahlquist is a rural journalist.

This story was found at:

Minute 31:50 (though the whole film is worth watching) Posted on October 09, 2015, 0 Comments

From the CDC website (

Do the 2014-2015 seasonal flu vaccines contain thimerosal?

The Food and Drug Administration (FDA) has approved several formulations of the seasonal flu vaccine, including multi-dose vials and single-dose units. (See Table of Approved Influenza Vaccines for the U.S. 2014–2015 Season.) Since seasonal influenza vaccine is produced in large quantities for annual vaccination campaigns, some of the vaccine is produced in multi-dose vials, and contains thimerosal to safeguard against possible contamination of the vial once it is opened.

I am pro vaccine. I had all of my six children vaccinated. I believe that vaccines save millions of lives. So let me explain why I oppose the current wave of state legislation to remove parents’ right to choose whether to give their children particular vaccines.

Vaccines are big business. Pharma is a trillion dollar industry  (1) with vaccines accounting for $25 billion in annual sales. (2) CDC’s decision to add a vaccine to the schedule can guarantee its manufacturer millions of customers and billions in revenue (3) with minimal advertising or marketing costs and complete immunity from lawsuits. High stakes and the seamless marriage between Big Pharma and government agencies have spawned an opaque and crooked regulatory system. Merck, one of America’s leading vaccine outfits, is currently under criminal investigation for fraudulently deceiving FDA regulators about the effectiveness of its MMR vaccine. Two whistleblowers say Merck ginned up sham studies to maintain Merck’s MMR monopoly. (4)

Big money has fueled the exponential expansion of CDC’s vaccine schedule since 1988, when Congress’ grant of immunity from lawsuits (5) suddenly transformed vaccines into paydirt. CDC recommended five pediatric vaccines when I was a boy in 1954. Today’s children cannot attend school without at least 56 doses of 14 vaccines by the time they’re 18. (6)

An insatiable pharmaceutical industry has 271 new vaccines under development in CDC’s bureaucratic pipeline (7) in hopes of boosting vaccine revenues to $100 billion by 2025. (8)The industry’s principle spokesperson, Dr. Paul Offit, says that he believes children can take as many as 10,000 vaccines. (9)

Public health may not be the sole driver of CDC decisions to mandate new vaccines. Four scathing federal studies by Congress, (10) the US Senate, (11) the HHS Inspector General, (12) and the HHS Office of Research Integrity, (13) paint CDC as a cesspool of corruption, mismanagement and dysfunction with alarming conflicts of interest suborning its research, regulatory and policymaking functions. CDC rules allow vaccine industry profiteers like Dr. Offit to serve on advisory boards that add new vaccines to the schedule. In a typical example, Offit in 1999 sat on the CDC’s vaccine advisory committee and voted to add the rotavirus vaccine to CDC’s schedule paving the way for him to make a fortune on his own rotavirus vaccine. (14) Offit and his business partners sold the royalties to his rotavirus vaccine patent to Merck in 2006 for $182 million. (15) Offit told Newsweek, “It was like winning the lottery!” (16) A 2009 HHS Inspector General’s report found that as many as 97% of the individuals who sit on the CDC advisory boards that approve vaccines may have similar conflicts. In addition to lucrative business partnerships with Merck, Offit holds a $1.5 million research chair, funded by Merck, at Children’s Hospital in Philadelphia. (17) From this industry sinecure, he broadcasts vaccine industry propaganda and annually publishes books urging unlimited vaccinations and vilifying safe-vaccine advocates. (18) (19)

The corruption has also poisoned CDC’s immunization safety office, the research arm that tests vaccines for safety and efficacy. In August 2014, seventeen year CDC veteran, Dr. William Thompson, who is author of the principal study cited by CDC to exculpate mercury preserved vaccines from the autism link, invoked whistleblower protection, and turned extensive agency files over to Congress. (20) Thompson, who is still employed at CDC, says that for the past decade his superiors have pressured him and his fellow scientists to lie and manipulate data about the safety of the mercury based preservative, thimerosal, to conceal its causative link to a suite of brain injuries, including autism. (21) (22)

Thimerosal is 50% ethylmercury which is far more toxic and persistent in the brain than the highly regulated methylmercury in fish. (23) Hundreds of peer reviewed studies by leading government and university scientists show that thimerosal, is a devastating brain poison linked to neurological disorders now epidemic in American children. My book, Thimerosal: Let the Science Speak, (24) is a summary of these studies, (25) which CDC and its credulous journalists swear don’t exist. Although Thompson’s CDC and vaccine industry colleagues have created nine patently fraudulent and thoroughly discredited epidemiological studies to defend thimerosal, no published study shows thimerosal to be safe. (26)

The common canard that US autism rates rose after drug makers removed most thimerosal from pediatric vaccines in 2003 is wrong. That same year, CDC added flu shots containing massive doses of thimerosal to the pediatric schedule. (27) As a result, children today can get nearly as much mercury exposure as children did from all pediatric vaccines combined in the decade prior to 2003. (28) Worse, thimerosal, for the first time, is being given to pregnant women in flu shots. (29) Furthermore, CDC’s current autism numbers are for children born in 2002, when kids were still getting thimerosal in their pediatric vaccines. The best science suggests that thimerosal’s complete removal from vaccines is likely to prompt a significant decline in autism. For example, a 2013 CDC study in JAMA Pediatrics shows a 33% drop in autism spectrum disorder in Denmark following the 1992 removal of thimerosal from Danish vaccines. (30) That paper is among 37 peer reviewed studies linking thimerosal to the autism epidemic. (31)

Thimerosal has precipitated a journalistic as well as a public health crisis. Big Pharma pumps over $3.5 billion annually into TV, newspapers and other advertising, targeting news departments, which have become vehicles for pharmaceutical sales and propaganda platforms for the industry. Television and print outlets feature spokespeople like Dr. Offit – without identifying their industry ties - while censoring criticisms of vaccine safety and excluding the voices of informed vaccine safety advocates. Busy journalists parrot the deceptive talking points dispensed by government and pharma officials rather than reading the science themselves. Unable to argue the science, they bully, pillory and demonize vaccine safety advocates as “anti-vax”, “anti-science” and far worse. The unwillingness of the press to scrutinize CDC has emboldened both industry and agency to follow the lowest paths of easy profit and bureaucratic preservation.

The measles scare was classic disaster capitalism with media outlets dutifully stoking public hysteria on editorial pages and throughout the 24 hour broadcast cycle. With Dr. Offit leading the charge, CDC, drug makers and industry funded front groups parlayed a garden variety annual measles outbreak into a national tidal wave of state legislation to ban religious and philosophical vaccine exemptions. The national media frenzy over 159 measles cases (32) left little room for attention to the the autism cataclysm which has debilitated 1 million American children since the pandemic began in 1989, (33) with 27,000 new cases annually. CDC refuses to call autism an “epidemic”. In defiance of hard science, and common sense, CDC and Offit have launched a denial campaign to gull reporters into believing the autism plague is an illusion created by better diagnosis. (34) (35) (36)

Big Pharma is among the nation’s largest political donors giving $31 million last year to national political candidates. (37) It spends more on political lobbying than any other industry, $3.0 billion from 1998 to 2014 (38) – double the amount spent by oil and gas and four times as much as defense and aerospace lobbyists. (39) By February, state legislators in 36 states were pushing through over one hundred new laws to end philosophical and religious vaccine exemptions. Many of those state lawmakers are also on the industry payroll. (40) You can see how much money bill sponsors from your state took from Big Pharma on

Normally plaintiffs’ tort lawyers would provide a powerful check and balance to keep vaccines safe and effective and regulators and policymakers honest. But Pharma’s dirty money has brought the industry immunity from lawsuits for vaccine injury no matter how dangerous the product. An obliging Congress disposed of the Seventh Amendment right to jury trial making it impossible for vaccine injured plaintiffs to sue pharmaceutical companies for selling unsafe vaccines. (41) That’s right! No Class Actions. No discovery. No depositions and little financial incentive for the industry to make vaccines safer.

Vaccine industry money has neutralized virtually all of the checks and balances that once stood between a rapacious pharmaceutical industry and our children. With the research, regulatory and policymaking agencies captured, the courts closed to the public, the lawyers disarmed, the politicians on retainer and the media subverted, there is no one left to stand between a greedy industry and vulnerable children, except parents. Now Big Pharma’s game plan is to remove parental informed consent rights from that equation and force vaccine hesitant parents to inject their children with potentially risky vaccines which the Supreme Court has called “unavoidably unsafe”. (42)

Ending exemptions is premature until we have a functioning regulatory agency and a transparent process. The best way to insure full vaccine coverage is for the vaccine program to win back public trust by ending its corrupt financial ties with a profit-making industry.

To educate yourselves about CDC corruption and the truth about vaccine science, download the movie Trace Amounts (43) and insist your legislators watch it before voting on any of these bills.






(An article detailing whistleblower allegations that they were forced to lie about the efficacy of the mumps vaccine in Merck’s MMR-II formulation)

5 (This is the 1986 National Childhood Vaccine Injury Act which granted legal immunity to vaccine manufacturers)

6 Current ACIP recommended vaccine schedule for infants, children and adolescents through age 18)






12 (97% of CDC officials on vaccine committees have corrupting financial entanglements and conflicts of interest).






18 (This reference includes a list of the books that Dr. Offit has published)

19 (This reference includes the articles and opinion pieces that Dr. Offit has penned)

20 (This statement, made directly by Dr. William Thompson, includes an admission that CDC researchers intentionally hid a link between the MMR vaccine and autism)

21 (This opinion piece by RKF Jr. includes admissions by Dr. William Thompson that the CDC forced him to lie regarding vaccine safety in light of the autism epidemic)

22 (This video includes direct statements made by Dr. William Thompson regarding malfeaseance at the CDC)


24 (Link to the book, “Thimerosal: Let the Science Speak”)

25 (A list of 74 peer reviewed studies, compiled by Ms. Lyn Redwood, regarding the dangers of thimerosal)

26 Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines is Safe, Dr. Brian Hooker et al. 2014. (Critique of six epidemological studies cited by CDC to exculpate thimerosal)

27 (This article details the recommendations made by the ACIP in 2003 for the annual pediatric flu shot)

28 (This article includes details the total level of mercury exposure prior to and after the addition of the flu shot to the pediatric and maternal schedule)


30 (See Table 3 which shows a 1.5% autism spectrum disorder prevalence in 1994 dropping to 1% in 2004).

31 (37 studies linking thimerosal to autism, Dr. Brian S. Hooker, 2015)


33 (This EPA study calls 1989 the “gateway year” for the upturn in autism cases in the U.S. and the beginning of the autism epidemic).

34 (In this research paper, Offit and his coauthor, Jeffrey Gerber, claim that increases in autism are “likely driven by broadened diagnostic criteria and increased awareness”)

35 (In contrast to the unsupported statement by Gerber and Offit, this paper from the UC Davis MIND Institute shows true increases in autism levels, far beyond that possible through “broadening diagnostic criteria and increased awareness”)

36 (Thimerosal, Let the Science Speak, pp. 19-20, details the dramatic rise in autism incidence in the U.S. starting in 1989)




40 (This link gives an example of industry donations to state lawmakers, i.e., the campaign funding profile of Dr. Richard Pan, a state senator who is heavily supported by the health care industry and is leading the charge to remove parental vaccine consent rights in California)


42 (The Supreme Court Bruesewitz v. Wyeth 2012 decision leading to the final abolishment of the rights of vaccine injured citizens to sue vaccine manufacturers)




How Aspartame got "approved" Posted on July 05, 2015, 0 Comments

The Dangers of Chemical Contraception Posted on June 24, 2015, 0 Comments

Br Med J. 1970 April 25; 2(5703): 203–209.
Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs
W. H. W. Inman, M. P. Vessey, Barbro Westerholm, and A. Engelund
Reports of thromboembolism following the use of oral contraceptives received by drug safety committees in the United Kingdom, Sweden, and Denmark have been analysed to investigate possible differences in the risks associated with the various preparations. For this purpose the numbers of reports of thromboembolism attributed to each product were compared with the distribution that would have been expected from market research estimates of sales, assuming that all products carried the same risk.

A positive correlation was found between the dose of oestrogen and the risk of pulmonary embolism, deep vein thrombosis, cerebral thrombosis, and coronary thrombosis in the United Kingdom. A similar association was found for venous thrombosis and pulmonary embolism in Sweden and Denmark. No significant differences could be detected between sequential and combined preparations containing the same doses of oestrogen, nor between the two oestrogens, ethinyloestradiol and mestranol.
Certain discrepancies in the data suggest that the dose of oestrogen may not be the only factor related to the risk of thromboembolism; thus there was a significant deficit of reports associated with the combination of mestranol 100 μg. with norethynodrel 2•5 mg. and a significant excess of reports associated with the combination of ethinyloestradiol 50 μg. with megestrol acetate 4 mg. An excess of reports also occurred with other combined preparations containing megestrol acetate.
The data obtained in earlier epidemiological studies were re-examined and, though no trend was obvious in any one of them, the combined results showed an excess of cases of thromboembolism at the highest dose of oestrogen.

Lancet. 1976 Mar 6;1(7958):509-11.
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.
Sagar S, Stamatakis JD, Thomas DP, Kakkar VV.
Deep-vein thrombosis (D.V.T.) was detected by the fibrinogen-uptake test in six out of a total of thirty-one young women undergoing emergency abdominal surgery who gave a history of recent oral contraceptive intake. In contrast, no D.V.T. developed in nineteen similar patients who were not on oral contraceptives (P less than 0.01). Plasma-antithrombin-III activity was significantly lower preoperatively in patients taking oral contraceptives; postoperative D.V.T. subsequently developed in three out of five patients with preoperative antithrombin-III activity below 50%. In seventy-eight dental patients undergoing molar extraction, antithrombin-III activity was measured before, during, and after operation. Activity fell in all patients during operation, but the fall was significantly greater in women taking oral contraceptives (P less than 0.01). The intra-operative fall in antithrombin-III activity was prevented by a small preoperative dose of subcutaneous heparin.

Am J Obstet Gynecol. 1975 Jul 15;122(6):688-92.
Conjugated estrogens and hypercoagulability.
von Kaulla E, Droegemueller W, von Kaulla KN.
A group of 11 menopausal women receiving 1.25 mg. of conjugated estrogens daily had coagulation tests to determine the development of hypercoagulability after taking 5 and 21 tablets. There was no essential change in thrombin generation or fibrinolytic activity as measured by euglobin lysis time. There was a shift toward hypercoagulability in all three parameters of the thrombelastograms. The decrease of the antithrombin III activity was not as pronounced following the administration of conjugated estrogens as had been the change associated with oral contraceptives. Fibrin monomers were observed in some women during the first week of Premarin therapy.

Arch Pathol. 1970 Jan;89(1):1-8.
Vascular lesions in women taking oral contraceptives.
Irey NS, Manion WC, Taylor HB.
Distinctive vascular lesions in association with thrombosis were found in arteries and veins in 20 relatively young women receiving oral contraceptives. These lesions were characterized by structural and histochemical changes in the intima and media. Occlusive thrombi were associated with relatively small, organized bases, the age of the latter measured in days to weeks. Nonocclusive and possibly earlier lesions were dominated by endothelial proliferation with minimal thrombus formation. It is postulated that this endothelial and intimal hyperplasia may be related to the steroids received and that it parallels similarly induced hyperplasias that have been found in cervical gland epithelium, in leiomyomas, and in a variety of mesenchymal derivatives under experimental conditions. Further control and experimental studies are required to clarify the possible relationship between these vascular lesions and oral contraceptives.

Br Med J. 1973 December 1; 4(5891): 507–512.
Cryptogenic Cerebral Embolism in Women Taking Oral Contraceptives
Karin Enzell and Gunnar Lindemalm
Fourteen women taking oral contraceptives were admitted during a five-year period because of acute cerebrovascular lesions. A diagnosis of major cerebral embolism was established in four of them. No source of embolism was found, and thorough investigation failed to reveal any predisposing illness. Cerebral embolism was a probable diagnosis in several of the remaining 10 patients. A comparison was made with the strokes occurring in women not taking contraceptive pills in corresponding age groups.

Lancet. 1973 Jun 23;1(7817):1399-404.
Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.
[No authors listed]
A large survey of 24 hospitals was conducted to identify associations between commonly used drugs and various diseases. The results of 3 such studies–on venous thromboembolism, gall bladder disease, and breast tumors–are summarized in this article. Trained nurses in various hospital wards interviewed admissions, asking questions designed to determine smoking behavior, coffee and tea drinking, drug use, marital status, and parity and menopausal status, where appropriate. This report specifically centers on associations between oral contraceptive use and development of the 3 conditions under study. Women reported on in this portion of the study were aged 20-44 years. Compared with nonusers, the estimate of relative risk for thromboembolism in users was 11, and the estimated attack rate attributable to oral contraceptives was 60/100,000 users/year. For gall bladder disease (surgically confirmed) the corresponding relative risk estimate was 2.0, and the estimated annual attack rate was 79/100,000. The frequency of gall bladder disease in women under 35 years was significantly higher in oral contraceptive users of 6-12 months duration, compared with women who had taken the pills for longer periods. Breast cancer studies showed no evidence of a higher risk in oral contraceptive users relative to nonusers. In fact, a negative association between oral contraceptive use and breast tumors was found, and this was more pronounced in women with fibroadenoma of the breast. Most of the women surveyed for this report took low-dose estrogen formulations, but the role of dose to the above findings was not investigated.
The finding of a positive correlation between the dose of oestrogen and the risk of coronary thrombosis is of special interest since previous studies have failed to provide clear evidence of a relationship between oral contraceptives and this condition.

Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1042-8.
Coagulation effects of oral contraception.
Bonnar J.
In Europe and North America, estrogen/progestogen oral contraception has been associated with an increase in venous thromboembolism, myocardial infarction, and stroke. These hazards are found mainly in smokers and in women over the age of 35. Venous thromboembolism appears to correlate with the estrogen dosage, and the arterial complications with both the estrogen and progestogen components. Blood coagulation and vascular thrombosis are intimately related. Estrogen/progestogen oral contraception affects blood clotting by increasing plasma fibrinogen and the activity of coagulation factors, especially factors VII and X; antithrombin III, the inhibitor of coagulation, is usually decreased. Platelet activity is also enhanced with acceleration of aggregation. These changes create a state of hypercoagulability that, to a large extent, appears to be counterbalanced by increased fibrinolytic activity. Studies of the oral contraceptives in current use show that the coagulation effects depend on the dosage of estrogen and the type of progestogen used in combination. Current research is aimed at finding the estrogen/progestogen formulations that induce the least changes in the coagulation system and other physiologic processes. In this respect, the new low-dose formulations are a major step forward and should reduce the risk of vascular thrombotic complications.

Lancet. 1980 May 24;1(8178):1097-101.
Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
Böttiger LE, Boman G, Eklund G, Westerholm B.
The introduction of low-oestrogen oral contraceptives in Sweden and the concomitant disappearance of high-dose preparations did not result in a lowering of the mortality of fertile women from thromboembolic disease. Morbidity due to thromboembolism seems to have fallen, and the number of thromboembolic incidents reported to the Swedish Adverse Drug Reaction Committee decreased dramatically. The decrease was due exclusively to a reduction in venous thromboembolic disease: the frequency of arterial complications (cerebral and coronary) remained constant.

Estrogen has many pro-clotting effects, and one of them is a decreased activity of vascular plasminogen activator. K. E. Miller and S. V. Pizzo, “Venous and arterial thromboembolic disease in women using oral contraceptives,” Am. J. Obst. Gyn. 144, 824, 1982. -Ray Peat, PhD

Am J Obstet Gynecol. 1982 Dec 1;144(7):824-7.
Venous and arterial thromboembolic disease in women using oral contraceptives.
Miller KE, Pizzo SV.
Vascular plasminogen activator was measured by means of a new chromogenic assay in 24 women who had suffered from oral contraceptive-associated thrombotic disease and was compared to that in a control group of 78 premenopausal women. Vascular plasminogen activator levels were significantly reduced in the subjects who had venous thrombosis but not in the five women who had arterial thrombosis (0.04 +/- 0.03 versus 0.38 +/- 0.31, respectively) when compared to the levels in the control group (0.19 +/- 0.20). Since vascular activator levels distribute in a non-Gaussian manner, cases and controls were also stratified into deciles. Seventeen subjects who had suffered from venous thrombosis were stratified in the lowest three deciles, and two subjects, in the fourth and fifth deciles. Subjects who had suffered from arterial thrombosis were in the fourth or higher deciles. The conclusion is that, although there is a correlation between low levels of vascular plasminogen activator and venous thrombosis, no such correlation exists for arterial thrombosis.

"Being on the newest kinds of pills, which contain the progestin hormones drospirenone, desogestrel, or gestodene along with estrogen, doubled the risk again, making it six to seven times as high as women who weren't using hormonal forms of birth control." -Brenda Goodman, MA

"For women who had never used any hormonal birth control, about 3.7 out of 10,000 were diagnosed with a blood clot in a vein in a year's time. Being on an older-generation pill that contained an estrogen and the progestin hormone levonorgestrel roughly doubled that risk, to 7.5 women out of 10,000 followed for one year.

"So what did the research show? Estrogen plus progestin used for women who still had their uterus study was stopped in 2002 when the research indicated an increased risk of breast cancer, heart disease, stroke, blood clots and urinary incontinence. Of interest, the risk of colorectal cancer went down, as did hip fractures.

The study of women taking only estrogen was stopped in 2004 when it was found that there was an increased risk of strokes and blood clots. The risk of breast cancer was uncertain, and there was no change in the risk of colorectal cancer. Hip fracture risk was decreased." -Debbie Jackson, PhD

Health Risks from GMO foods and Glyphosate based herbicides Posted on June 10, 2015, 0 Comments

Lipitor Laughs Posted on April 15, 2015, 0 Comments

Probably the Most Hilarious Anti-Big Pharma Video I've Ever Seen

Probably the most hilarious anti-Big Pharma video I've ever seen (and so true)

Posted by AltHealthWORKS on Sunday, January 18, 2015

Big Pharma Marketing to Doctors Posted on February 12, 2015, 0 Comments

The Story of an Egg Posted on January 16, 2015, 0 Comments

Monsanto: Extinction Posted on November 28, 2014, 0 Comments

Guy Voyer on the creation of ELDOA exercise Posted on October 07, 2014, 3 Comments


I've studied with Dr. Voyer for a while now, and the education never stops.  I'm headed to L.A. later this week for some more work with one of the men who has changed how I and other health practitioners around the world work with their clients and patients.  ELDOA, myofascial stretching, and many of the other techniques I'm learning under Dr. Voyer's tutelage are what the fields of rehab and performance have been missing.  As a SOMA practitioner, I'm happy to be able to provide them to the clients of Triumph Training.

The Psychology of Cycling Posted on August 13, 2014, 0 Comments

Unacceptable Levels Posted on June 01, 2014, 0 Comments

Yekra Player

Yekra is a revolutionary new distribution network for feature films.

Unacceptable Levels


Unacceptable Levels examines the results of the chemical revolution of the 1940s through the eyes of affable filmmaker Ed Brown, a father seeking to understand the world in which he and his wife are raising their children. To create this debut documentary, one man and his camera traveled extensively to find and interview top minds in the fields of science, advocacy, and law. Weaving their testimonies into a compelling narrative, Brown presents us with the story of how the chemical revolution brought us to where we are, and of where, if we’re not vigilant, it may take us.


Truth Vaccine Posted on April 16, 2014, 1 Comment

Contributors to my Race Across America (RAAM) effort to raise funds for LLS Posted on March 10, 2014, 0 Comments

It takes a team....

Gratitude for all my supporters and friends below:


Genevieve Barber

Ruth Bartlett

Jill Bidwell

Hanns and Angie Billmayer

Jim Bilotto

Scott and Teresa Bonder

Evan and Erin Bower

Wes and Amy Bryant

Mike and Gallie Coles

Chad and Pam Dittmer

Stephen and Katrina Dooda

Dragon Fly Reiki

Chapin Ellinger

Bill Fair

Jonathan Freeman

Woody and Leslie Galloway

Ashley Gardner

Nancy Garfield

Margaret Graff

Casey Hannan

Richard Higgins

Allen and Jacque Hill

Holistic Strength Training for Triathlon

Woody and Carol Hughes

Mike and Kathy Jennings

Bill and Jennifer Jestel

Derek Johnson

Stewart and Sharon Johnston

Chase Jordan

Doug and Rhoda Joyner

Eric and Maureen Joyner

Jill Joyner Bush

Stephen Julien

Mike and Nanci King

Rob King

Jennifer Kjellgren

Steven Kushner

Karen Lang

Angela Laughter

Ralph Lloyd

Rachel Locascio

Brian and Carrie Montgomery

Christopher Moorman

Mary Charlie Murphree

Donald and Kim Nelson

Bobby and Amy Pearce

Lauren Ramsey

Brent and Ellianne Rivers

Gordon and Susan Rose

Layne Savoie

David Sawyer

Greg Schisla

Kerri Shannon

Randall Shearin

Ross and Kira Sloop

Arthur and Barbara Sohn

Jean Steusloff

Kathrine Tan

Allan Taylor

Kathryn Taylor

Cameron Thomas

Triumph Training

Allen and Jill Travis

Mike and Heather Weisenborn

Matt and Kelly Wheeler

Pam White

Brian Woodworth

Jonathan and Bethany Yearty

Jean York

Joe Younkins




Essential Tips for Health (Personal and Global) Posted on March 04, 2014, 0 Comments

My Mentor with Tips for Pain Free Driving Posted on February 05, 2014, 0 Comments

The Power of Thought Posted on January 19, 2014, 0 Comments

8 Stages of Running a Marathon Posted on October 05, 2013, 0 Comments

Diana Nyad: It's Not About the Swim Posted on September 02, 2013, 0 Comments

Blood Tests and "Normal" levels of Thyroid Posted on June 22, 2013, 0 Comments